News

The UN has released its annual report on global cybersecurity. The report aims to measure which countries are most committed to making the web more secure, scoring countries according to five pillars: technical, organizational, legal, cooperation and growth potential.

The FDA first authorized the use of Dignicap in April to thwart chemo-related hair loss in patients undergoing chemotherapy for breast cancer. The agency has now expanded the cap’s use to include patients with all types of solid tumors. The device circulates cool liquid to minimize the effects of chemo drugs on hair follicles.

The acquisition positions Roche to enhance interoperability and integration with its Accu-Chek line of blood glucose monitors.

"Whether such artificial-intelligence systems are ‘smarter’ than human practitioners makes for a stimulating debate—but is largely irrelevant," they write.

The recent attack ravaged everything from Maersk to Merck. It also impacted small health systems in the US, whether it meant to or not.

Using the same exploit as WannaCry, a new attack is ravaging computer systems worldwide.

“With telemedicine, distance is no longer an impediment to receiving health care services from anywhere in Pennsylvania or across the country,” says State Senator Elder Vogel.

Experts compare existing paging methods within hospitals to "paved cowpaths."

Morris Panner spoke to HCA News about the interoperability landscape and his company's change from DICOM Grid to Ambra Health.

Morris Panner, CEO of Ambra Health, gave a detailed interview on interoperability, artificial intelligence, value-based care, and the business of running a health tech company.

Oscar Insurance, co-founded by Jared Kushner's brother, announced expansion the day before details of GOP health bill emerged.

Two years after the ResearchKit launch, studies using the platform seem to suffer from the same issues it was meant to address.

The company's name will now appear on Withings smart scales and wearables. The devices and the app combine to form an "ecosystem" that Nokia hopes will provide "a 360-degree view of their well-being."

Can drug manufacturers use colossal swaths of data to deliver new pharmaceuticals more efficiently and cost-effectively? And if so, will those savings some day make their way to the patients?

Another week, another IT security threat with a conveniently catchy name: the U.S. Department of Health and Human Services late last week released a warning about a new threat, or series of threats, that could impact healthcare systems.

Experts say that the problem will only get worse, and exponentially so. Still, much can be learned from the recent WannaCry attack.

In the name of an “efficient, risk-based approach” to regulation in order to “promote health” through innovation, Gottlieb detailed a number of initiatives underway or soon to be.

"We are pitting the enthusiasm of the futurists...against the public health perspective that says ‘be careful what you screen for,’” the prominent genomicist says.

The FDA, GINA, and variants of unknown significance all muddy the waters of genomic research and data storage.

Certainly, Walton believes greatly in the potential of genomics to change medicine at its core, but the obstacles preceding that shift are numerous and substantial, he argued.

"It truly can transform how we diagnose and treat cancer patients. They've just never had these kinds of tools before," says the Hackensack Meridian Health co-CEO.

"If this were a drug that had a survival advantage of this magnitude, it would be retail priced at hundreds of thousands of dollars."

Cerner Corp. nailed down a $4 billion-plus Department of Defense contract in 2015. The deal with the VA bypassed the typical public bidding process.

Trio will pilot program to leverage Watson's computational power to determine value-based treatment options for cancer patients.

Data scientists and clinical researchers collaborate on MiSL, or “Mining Synthetic Lethals,” to identify genetic duos within tumors that allow cancer to survive.

Of all of the conditions that technological innovation has the potential to mitigate, assuage, and aid, vision loss leaves plenty of room for the novel and life-changing.

"My particular joy is in innovation, and trying to innovate before the problem occurs, before the pain is really felt, and having a solution ready for when it does hit," Suit says.

Recent reports of a new team at the FDA that will try to match healthtech's pace of innovation mesh with previous writings by the Administration's recently-appointed head, Scott Gottlieb.

When it was a mere "online bookseller," Amazon invested in 40% of an online pharmacy that didn't quite pan out. Now the preeminint online retail giant, the company is believed to be taking another look at the complex industry.

SCIO Health Analytics' Chief Evangelist argues for the use of analytics to prevent complications and provide true value-based care.